Clinical Trial Update: A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis [Phase 3]

View source ↗

Summary

This is a Phase 3 rollover study evaluating long-term safety and efficacy of ocrelizumab in patients with multiple sclerosis. The study is currently not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Multiple Sclerosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING